ATE265217T1 - Antikrebs-therapeutische zusammensetzungen die molke-proteinkonzentrat enthalten - Google Patents

Antikrebs-therapeutische zusammensetzungen die molke-proteinkonzentrat enthalten

Info

Publication number
ATE265217T1
ATE265217T1 AT93917476T AT93917476T ATE265217T1 AT E265217 T1 ATE265217 T1 AT E265217T1 AT 93917476 T AT93917476 T AT 93917476T AT 93917476 T AT93917476 T AT 93917476T AT E265217 T1 ATE265217 T1 AT E265217T1
Authority
AT
Austria
Prior art keywords
whey protein
protein concentrate
compositions containing
therapeutic compositions
cancer therapeutic
Prior art date
Application number
AT93917476T
Other languages
English (en)
Inventor
Phil Gold
Gustavo Bounous
Original Assignee
Immunotec Res Corp Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunotec Res Corp Ltd filed Critical Immunotec Res Corp Ltd
Application granted granted Critical
Publication of ATE265217T1 publication Critical patent/ATE265217T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Steroid Compounds (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT93917476T 1992-08-13 1993-08-05 Antikrebs-therapeutische zusammensetzungen die molke-proteinkonzentrat enthalten ATE265217T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92934792A 1992-08-13 1992-08-13
PCT/CA1993/000309 WO1994004168A1 (en) 1992-08-13 1993-08-05 Anti-cancer therapeutic compositions containing whey protein concentrate

Publications (1)

Publication Number Publication Date
ATE265217T1 true ATE265217T1 (de) 2004-05-15

Family

ID=25457715

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93917476T ATE265217T1 (de) 1992-08-13 1993-08-05 Antikrebs-therapeutische zusammensetzungen die molke-proteinkonzentrat enthalten

Country Status (15)

Country Link
EP (1) EP0655925B1 (de)
JP (2) JP4115515B2 (de)
KR (1) KR100297610B1 (de)
CN (1) CN1088095A (de)
AT (1) ATE265217T1 (de)
AU (1) AU687356B2 (de)
CA (1) CA2142277C (de)
CZ (1) CZ295849B6 (de)
DE (1) DE69333497T2 (de)
IL (1) IL106576A (de)
MX (1) MX9304925A (de)
NZ (1) NZ254704A (de)
TW (1) TW380051B (de)
WO (1) WO1994004168A1 (de)
ZA (1) ZA935918B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP494798A0 (en) 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
TWI438675B (zh) 2010-04-30 2014-05-21 Ibm 提供情境感知援助說明之方法、裝置及電腦程式產品
CN102232556A (zh) * 2010-04-30 2011-11-09 李德远 一种抗偏二甲肼的食品添加剂
US20150344534A1 (en) * 2011-12-07 2015-12-03 Arla Foods Amba Osteopontin variants for use in suppression or prevention of tumor growth and compositions containing such osteopontin variants
DE102014001037A1 (de) * 2014-01-25 2015-07-30 Gea Tds Gmbh Verfahren und Vorrichtung zur Reduzierung des Wachstums thermophiler Keime in Magermilch
CN104146269B (zh) * 2014-07-28 2015-08-19 苏喜生 一种用于抗偏二甲肼的应激食品添加剂及其制备方法
CN105831769A (zh) * 2015-02-04 2016-08-10 张亚武 一种细胞内/细胞间对癌症抑制之食物
CA3038048A1 (en) 2016-09-23 2018-03-29 Immunotec Inc. Compositions for restoring gene expression in neuropsychiatric or neurodegenerative disorders
CA2970699A1 (en) 2017-06-14 2018-12-14 Elizabeth E. Ignowski Compositions for increasing resilience to traumatic brain injury
WO2019027974A1 (en) 2017-07-31 2019-02-07 Immunotec Inc. Compositions and methods for treatment of autism spectrum disorder

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3628010A1 (de) * 1986-08-19 1988-02-25 Astra Chem Gmbh Arzneimittel fuer die verwendung bei der behandlung von hypertonie
DE3870247D1 (de) * 1988-12-21 1992-05-21 Siemens Ag Schienenfahrzeug.
CA1338682C (en) * 1988-12-23 1996-10-29 Gustavo Bounous Biologically active undenatured whey protein concentrate as food supplement
JPH03216156A (ja) * 1990-01-22 1991-09-24 Gustavo Bounous 生物学的に活性なホエータンパク質組成物、その製法および組成物の使用法

Also Published As

Publication number Publication date
AU4693793A (en) 1994-03-15
NZ254704A (en) 1997-08-22
DE69333497T2 (de) 2005-01-13
IL106576A (en) 2000-08-13
JP4115515B2 (ja) 2008-07-09
CN1088095A (zh) 1994-06-22
AU687356B2 (en) 1998-02-26
EP0655925A1 (de) 1995-06-07
CA2142277A1 (en) 1994-03-03
TW380051B (en) 2000-01-21
WO1994004168A1 (en) 1994-03-03
DE69333497D1 (de) 2004-06-03
ZA935918B (en) 1994-03-09
KR100297610B1 (ko) 2001-10-24
KR950702837A (ko) 1995-08-23
CZ295849B6 (cs) 2005-11-16
IL106576A0 (en) 1993-12-08
JP2008115194A (ja) 2008-05-22
EP0655925B1 (de) 2004-04-28
CZ28395A3 (en) 1995-10-18
CA2142277C (en) 2000-01-18
JPH08500108A (ja) 1996-01-09
MX9304925A (es) 1994-08-31

Similar Documents

Publication Publication Date Title
NO169291C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt tetrapyrrol-amino-dicarboxylsyreaddukt
FR2442054A1 (fr) Proteines purifiees, notamment interferon, procede de preparation et compositions pharmaceutiques les contenant
UA42747C2 (uk) Похідні пептиду,фармацевтична композиція та спосіб стимулювання секреції гормону росту
MX9702932A (es) L-ribofuranosilnucleosidos.
MY110734A (en) Improvements in or relating to dioic acids.
ATE122885T1 (de) Mittel zur behandlung von herzerkrankungen.
FI900808A0 (fi) Humant mannos bindande protein.
NZ314839A (en) 1,25-Dihydroxy-16,23Z-diene-20-epi-16-ene-cholecalciferol (Vitamin D3) analogues
DE69333497D1 (de) Antikrebs-therapeutische zusammensetzungen die molke-proteinkonzentrat enthalten
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
BE900012A (fr) Nouveau peptide.
MX9702926A (es) L-eritrosilnucleosidos.
ATE159171T1 (de) Arzneimittelzusammensetzung enthaltend tcf-ii
DE3163920D1 (en) Pharmaceutical preparations comprising polyprenyl compounds, especially as anti-cancer agents, and pharmaceutical compositions for the prevention and treatment of cancer and skin diseases
MX9702927A (es) L-piranosilnucleosidos.
DE3374066D1 (en) N-acyl derivatives of peptides, their manufacture and use in combating diseases and means therefor
ATE65027T1 (de) Behandlung von parasiterkrankungen.
KR0177821B1 (en) Pharmaceutical compositions containing 1,2-benzopyrone derivatives for the treatment of malignant tumours in humans
IT1172264B (it) Enzima simile a pepsina da leucocito umano,procedimento per prepararlo,e composizione terapeutica che lo continene come ingrediente attivo
FR2592302A1 (fr) Compositions cosmetiques pour le traitement de la peau et des cheveux gras, a base de di(beta-hydroxyethyl) sulfoxyde, et leur application.
IT1244459B (it) Composizione terapeutica per il trattamento di malattie della pelle quali vitiligine,acne,psoriasi,alopecia,ipotricosi
IT1268409B1 (it) Prodotto per il trattamento terapeutico di dermatiti da contatto e psoriasi

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties